Detalhe da pesquisa
1.
Molecular and Cellular Characterization of Primary Endothelial Cells from a Familial Cavernomatosis Patient.
Int J Mol Sci
; 25(7)2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612762
2.
The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases.
Int J Mol Sci
; 23(8)2022 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35457036
3.
Blockade of ß2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma.
Int J Mol Sci
; 23(3)2022 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163250
4.
Identification of Exosomal MicroRNA Signature by Liquid Biopsy in Hereditary Hemorrhagic Telangiectasia Patients.
Int J Mol Sci
; 22(17)2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34502358
5.
Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).
Health Qual Life Outcomes
; 15(1): 19, 2017 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28114930
6.
MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells.
Angiogenesis
; 16(4): 877-87, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23800974
7.
Tacrolimus as a Promising Drug for Epistaxis and Gastrointestinal Bleeding in HHT.
J Clin Med
; 12(23)2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38068462
8.
Propranolol: A "Pick and Roll" Team Player in Benign Tumors and Cancer Therapies.
J Clin Med
; 11(15)2022 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35956154
9.
A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2.
J Clin Med
; 11(11)2022 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35683441
10.
Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds.
J Clin Med
; 10(17)2021 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34501293
11.
SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population.
J Clin Med
; 10(9)2021 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33925423
12.
eHealth for patients with rare diseases: the eHealth Working Group of the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN).
Orphanet J Rare Dis
; 16(1): 164, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33832526
13.
CLN5 in heterozygosis may protect against the development of tumors in a VHL patient.
Orphanet J Rare Dis
; 15(1): 132, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32487141
14.
Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding.
J Clin Med
; 9(6)2020 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32517280
15.
Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa.
Cells
; 9(9)2020 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947957
16.
Targeting ß2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel-Lindau Disease.
J Clin Med
; 9(9)2020 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32854260
17.
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.
Orphanet J Rare Dis
; 14(1): 28, 2019 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30717761
18.
Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition).
TH Open
; 3(3): e230-e243, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31360828
19.
11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells.
Sci Rep
; 9(1): 11916, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31417117
20.
Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
Thromb Haemost
; 97(2): 254-62, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17264955